| 編號 | 商品編號 | 商品名稱 | 作者 | 類別 | 使用課程名稱 |
| 1 | 9-201-056 | Pharmacyclics: Financing Research & Development | Ruback, Richard S.;Baker, Malcolm P.;Sesia, Aldo | Finance | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |
| 2 | 9-213-047 | Aqua Bounty | White, Lucy;Burn-Murdoch, Stephen | Finance | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |
| 3 | 9-293-087 | ImmuLogic Pharmaceutical Corp. (Abridged) | Lerner, Josh | Finance | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |
| 4 | 9-298-070 | Genset--1989 | Gompers, Paul A.;Burroughs, Amy L. | Finance | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |
| 5 | UV6874 | Sanofi-Aventis''s Tender Offer for Genzyme | Eades, Kenneth;Matos, Pedro;Aleyev, Dmitriy;Xu, Chong | Finance | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |
| 6 | 9-615-007 | Netflix in 2011 | Shih, Willy;Kaufman, Stephen P. | Other | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |
| 7 | NTU053 | Biosensors International Group: Valuation and Impairment Testing of Intangibles | Tan, Patricia;Jian, Ming | Other | Investment Analysis for Biopharmaceutical Industry( 932317005 ) |